Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study.
Saved in:
| Title: | Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. |
|---|---|
| Authors: | Harrison SA; Hepatology, Radcliffe Department of Medicine, University of Oxford, UK. Electronic address: sharrison@pinnacleresearch.com., Alkhouri N; Texas Liver Institute, San Antonio, TX, USA., Davison BA; Momentum Research, Inc., Durham, NC, USA., Sanyal A; Virginia Commonwealth University School of Medicine, Richmond, VR, USA., Edwards C; Momentum Research, Inc., Durham, NC, USA., Colca JR; Cirius Therapeutics, Inc., San Diego, CA, USA., Lee BH; Cirius Therapeutics, Inc., San Diego, CA, USA., Loomba R; NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA., Cusi K; University of Florida, Gainesville, FL, USA., Kolterman O; Pendulum Therapeutics, San Francisco, CA, USA., Cotter G; Momentum Research, Inc., Durham, NC, USA., Dittrich HC; Cirius Therapeutics, Inc., San Diego, CA, USA. |
| Source: | Journal of hepatology [J Hepatol] 2020 Apr; Vol. 72 (4), pp. 613-626. Date of Electronic Publication: 2019 Nov 04. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31697972 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Harrison+SA%22">Harrison SA</searchLink>; Hepatology, Radcliffe Department of Medicine, University of Oxford, UK. Electronic address: sharrison@pinnacleresearch.com.<br /><searchLink fieldCode="AU" term="%22Alkhouri+N%22">Alkhouri N</searchLink>; Texas Liver Institute, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Davison+BA%22">Davison BA</searchLink>; Momentum Research, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sanyal+A%22">Sanyal A</searchLink>; Virginia Commonwealth University School of Medicine, Richmond, VR, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+C%22">Edwards C</searchLink>; Momentum Research, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Colca+JR%22">Colca JR</searchLink>; Cirius Therapeutics, Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+BH%22">Lee BH</searchLink>; Cirius Therapeutics, Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Loomba+R%22">Loomba R</searchLink>; NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cusi+K%22">Cusi K</searchLink>; University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kolterman+O%22">Kolterman O</searchLink>; Pendulum Therapeutics, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cotter+G%22">Cotter G</searchLink>; Momentum Research, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Dittrich+HC%22">Dittrich HC</searchLink>; Cirius Therapeutics, Inc., San Diego, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228503886%22">Journal of hepatology</searchLink> [J Hepatol] 2020 Apr; Vol. 72 (4), pp. 613-626. <i>Date of Electronic Publication: </i>2019 Nov 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8503886 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0641 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201688278%22">01688278 </searchLink><i>NLM ISO Abbreviation: </i>J Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31697972 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jhep.2019.10.023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 613 Titles: – TitleFull: Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Harrison SA – PersonEntity: Name: NameFull: Alkhouri N – PersonEntity: Name: NameFull: Davison BA – PersonEntity: Name: NameFull: Sanyal A – PersonEntity: Name: NameFull: Edwards C – PersonEntity: Name: NameFull: Colca JR – PersonEntity: Name: NameFull: Lee BH – PersonEntity: Name: NameFull: Loomba R – PersonEntity: Name: NameFull: Cusi K – PersonEntity: Name: NameFull: Kolterman O – PersonEntity: Name: NameFull: Cotter G – PersonEntity: Name: NameFull: Dittrich HC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2020 Apr Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1600-0641 Numbering: – Type: volume Value: 72 – Type: issue Value: 4 Titles: – TitleFull: Journal of hepatology Type: main |
| ResultId | 1 |
